Literature DB >> 23885911

Oncolytic virotherapy.

Daniel Y Sze1, Tony R Reid, Steven C Rose.   

Abstract

Oncolytic virotherapy is an emerging technology that uses engineered viruses to treat malignancies. Viruses can be designed with biological specificity to infect cancerous cells preferentially, and to replicate in these cells exclusively. Malignant cells may be killed directly by overwhelming viral infection and lysis, which releases additional viral particles to infect neighboring cells and distant metastases. Viral infections may also activate the immune system, unmask stealthy tumor antigens, and aid the immune system to recognize and attack neoplasms. Delivery of live virus particles is potentially complex, and may require the expertise of the interventional community.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2013        PMID： 23885911     DOI： 10.1016/j.jvir.2013.05.040

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN： 1051-0443            Impact factor:   3.464


  31 in total

1.  Oncolytic Poxviruses.

Authors:  Winnie M Chan; Grant McFadden
Journal:  Annu Rev Virol       Date:  2014-09-01       Impact factor: 10.431

2.  Chemovirotherapy for pancreatic cancer: Gemcitabine plus oncolytic measles vaccine virus.

Authors:  Verena May; Susanne Berchtold; Alexander Berger; Sascha Venturelli; Markus Burkard; Christian Leischner; Nisar P Malek; Ulrich M Lauer
Journal:  Oncol Lett       Date:  2019-09-20       Impact factor: 2.967

Review 3.  Targeting cancer stem cells with oncolytic virus.

Authors:  Yin Tong; Wenbin Qian
Journal:  Stem Cell Investig       Date:  2014-11-28

Review 4.  Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors.

Authors:  Jonathan G Pol; Sarah Lévesque; Samuel T Workenhe; Shashi Gujar; Fabrice Le Boeuf; Derek R Clements; Jean-Eudes Fahrner; Laetitia Fend; John C Bell; Karen L Mossman; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2018-08-27       Impact factor: 8.110

Review 5.  Signal pathways and precision therapy of small-cell lung cancer.

Authors:  Min Yuan; Yu Zhao; Hendrik-Tobias Arkenau; Tongnei Lao; Li Chu; Qing Xu
Journal:  Signal Transduct Target Ther       Date:  2022-06-15

Review 6.  Viruses for tumor therapy.

Authors:  John Bell; Grant McFadden
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

Review 7.  Gene therapy in pancreatic cancer.

Authors:  Si-Xue Liu; Zhong-Sheng Xia; Ying-Qiang Zhong
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

8.  A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4.

Authors:  Wen Zhang; Keli Ge; Qian Zhao; Xiufen Zhuang; Zhenling Deng; Lingling Liu; Jie Li; Yu Zhang; Ying Dong; Youhui Zhang; Shuren Zhang; Binlei Liu
Journal:  Oncotarget       Date:  2015-08-21

Review 9.  Progress in gene therapy using oncolytic vaccinia virus as vectors.

Authors:  Xue Yang; Biao Huang; Lili Deng; Zhigang Hu
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-06       Impact factor: 4.322

10.  Multi-wavelength photoacoustic imaging of inducible tyrosinase reporter gene expression in xenograft tumors.

Authors:  Robert J Paproski; Andrew Heinmiller; Keith Wachowicz; Roger J Zemp
Journal:  Sci Rep       Date:  2014-06-17       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.